{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:54:39Z","timestamp":1790812479573,"version":"4.1.0"},"reference-count":48,"publisher":"Informa UK Limited","issue":"17","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Biomark. Med."],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.2217\/bmm-2023-0052","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T15:03:44Z","timestamp":1702393424000},"page":"711-721","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic Value of the Lung Immune Prognostic Index for HER-2-Negative Metastatic Gastric Cancer"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9622-1198","authenticated-orcid":false,"given":"Miaomiao","family":"Gou","sequence":"first","affiliation":[{"name":"Medical Oncology Department, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, the Second Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Qu","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, the Fifth Affiliated Hospital Sun YAT-SEN University, Zhuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Jia","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghai","family":"Dai","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31827-5"},{"issue":"4","key":"e_1_3_6_4_1","first-page":"579","article-title":"Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial","volume":"5","author":"Fuchs CS","year":"2019","unstructured":"Fuchs CS , Doi T , Jang RW et al. Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE-059 trial. JAMA Oncol. 5(4), 579 (2019).","journal-title":"JAMA Oncol."},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.9929"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"e_1_3_6_7_1","volume-title":"2019 Gastrointestinal Cancers Symposium","author":"Kojima T","year":"2019","unstructured":"Kojima T et al. Pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer: phase III KEYNOTE-181 study. Presented at: 2019 Gastrointestinal Cancers Symposium (2019)."},{"issue":"10314","key":"e_1_3_6_8_1","first-page":"1874","article-title":"Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: the phase 3 KEYNOTE-590 study","volume":"398","author":"Ken Kato ea","year":"2021","unstructured":"Ken Kato ea . Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: the phase 3 KEYNOTE-590 study. Lancet 398(10314), 1874 (2021).","journal-title":"Lancet"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00797-2"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.8429"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_175228"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy540"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30445-9"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0101-z"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.07.001"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.02.006"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2008.05.046"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2024"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8345286"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.467"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5903-y"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-1167-x"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9459"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2018.02.014"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13606"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13083"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.4771"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111713"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S277453"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.1747"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.23736\/S1824-4785.20.03250-1"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx059"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0383-1"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S180695"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108345"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4381"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2013.09.008"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-018-0897-8"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0127"},{"issue":"5","key":"e_1_3_6_42_1","first-page":"449","article-title":"Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma","volume":"63","author":"Kelderman S","year":"2014","unstructured":"Kelderman S , Heemskerk B , van Tinteren H et al. Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma. Cancer Immunol. Immunother. 63(5), 449\u2013458 (2014).","journal-title":"Cancer Immunol. Immunother."},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-016-2330-1"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-017-1587-6"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101748"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.04.006"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-35723-8_1"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw016"},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-020-00716-y"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S138039"}],"container-title":["Biomarkers in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/bmm-2023-0052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:40:52Z","timestamp":1719124852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/bmm-2023-0052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":48,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.2217\/bmm-2023-0052"],"URL":"https:\/\/doi.org\/10.2217\/bmm-2023-0052","relation":{},"ISSN":["1752-0363","1752-0371"],"issn-type":[{"value":"1752-0363","type":"print"},{"value":"1752-0371","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}